Is a complete PLSE research report available?

No complete published report is available for Pulse Biosciences, Inc. (PLSE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pulse Biosciences, Inc. (PLSE)

NASDAQ: PLSE · USD

$53.5

+0.28 (+0.5%)· Recorded snapshot

Market cap	3.8B
Revenue (ttm)	1.2M
Net income (ttm)	-80.1M
EPS (ttm)	-$1.18
Shares out	71.3M
Volume	238,351
Beta	1.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.2M
Net income (ttm): -80.1M
EPS (ttm): -$1.18
Market cap: 3.8B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001625101
Company name	Pulse Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	74587B101
Earnings date	2026-11-05
Earnings time	amc
Employees	116
Employees change	41
Employees growth	54.67%
Enterprise value	$3.7B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2014
In index	RUSSELL2000
Industry	Medical Instruments & Supplies
IPO date	2016-05-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US74587B1017
Last 10-K release date	2026-02-19
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.8B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$53.48
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PLSE
U.S. state	Florida
Website	https://www.pulsebiosciences.com

Metric

Value

Amount currency

USD

CIK code

0001625101

Company name

Pulse Biosciences, Inc.

Country

United States

Country code

CUSIP number

74587B101

Earnings date

2026-11-05

Earnings time

amc

Employees

116

Employees change

Employees growth

54.67%

Enterprise value

$3.7B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2014

In index

RUSSELL2000

Industry

Medical Instruments & Supplies

IPO date

2016-05-18

Is primary listing

Yes

Is SPAC

ISIN number

US74587B1017

Last 10-K release date

2026-02-19

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$3.8B

Market cap category

Mid-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$53.48

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

PLSE

U.S. state

Florida

Website

https://www.pulsebiosciences.com

Metric	Value
Earnings yield	-2.2%
EV/Sales	3,155.06x
FCF / EV yield	-1.64%
FCF yield	-1.6%
Forward EV/Sales	1,265.94x
Forward P/S	1,298.05x
Industry forward P/E	22.69x
Industry P/E	75.18x
P/B ratio	37.85x
P/S ratio	3,235.1x
Price / tangible book value	39.73x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-2.2%

EV/Sales

3,155.06x

FCF / EV yield

-1.64%

FCF yield

-1.6%

Forward EV/Sales

1,265.94x

Forward P/S

1,298.05x

Industry forward P/E

22.69x

Industry P/E

75.18x

P/B ratio

37.85x

P/S ratio

3,235.1x

Price / tangible book value

39.73x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Gross margin	0.25%
Operating margin	-7,058.4%
Pretax margin	-6,755.78%
Profit per employee	$-690,138
Revenue per employee	$10,216
ROA	-44.34%
ROA (5Y)	-51.24%
ROCE	-79.97%
ROE	-78.49%
ROE (5Y)	-181.89%
ROIC	-47.74%
SBC / revenue	1,474.43%

Metric

Value

Gross margin

0.25%

Operating margin

-7,058.4%

Pretax margin

-6,755.78%

Profit per employee

$-690,138

Revenue per employee

$10,216

ROA

-44.34%

ROA (5Y)

-51.24%

ROCE

-79.97%

ROE

-78.49%

ROE (5Y)

-181.89%

ROIC

-47.74%

SBC / revenue

1,474.43%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth (QoQ)	8.23%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth (QoQ)

8.23%

Revenue growth years

Metric	Value
Capital expenditures	$-290,000
Depreciation and amortization	$1M
EBIT	$-83.6M
EBITDA	$-82.6M
EPS	$-1.18
FCF per share	$-0.86
Financing cash flow	$56.7M
Free cash flow	$-61.4M
Free cash flow minus SBC	$-78.9M
Gross profit	$3,000
Investing cash flow	$-290,000
Net cash flow	$-4.7M
Net income	$-80.1M
Operating cash flow minus SBC	$-78.6M
Operating income	$-83.6M
Revenue	$1.2M
Stock-based compensation	$17.5M

Metric

Value

Capital expenditures

$-290,000

Depreciation and amortization

$1M

EBIT

$-83.6M

EBITDA

$-82.6M

EPS

$-1.18

FCF per share

$-0.86

Financing cash flow

$56.7M

Free cash flow

$-61.4M

Free cash flow minus SBC

$-78.9M

Gross profit

$3,000

Investing cash flow

$-290,000

Net cash flow

$-4.7M

Net income

$-80.1M

Operating cash flow minus SBC

$-78.6M

Operating income

$-83.6M

Revenue

$1.2M

Stock-based compensation

$17.5M

Metric	Value
Altman Z-Score	38.97
Book value per share	$1.41
Debt / equity	0.07
Goodwill	$2.8M
Long-term assets	$9.9M
Long-term liabilities	$5.1M
Net cash (debt)	$94.8M
Net cash / market cap	2.47%
Net cash growth	-3.32%
Net debt / equity	-0.95
Piotroski F-Score	1
Property, plant and equipment	$6.4M
Shareholders' equity	$99.5M
Tangible book value	$96.5M
Tangible book value per share	$1.36
Total assets	$115.6M
Total cash	$101.6M
Total debt	$6.8M
Total liabilities	$16.1M
WACC	12.86%

Metric

Value

Altman Z-Score

38.97

Book value per share

$1.41

Debt / equity

0.07

Goodwill

$2.8M

Long-term assets

$9.9M

Long-term liabilities

$5.1M

Net cash (debt)

$94.8M

Net cash / market cap

2.47%

Net cash growth

-3.32%

Net debt / equity

-0.95

Piotroski F-Score

Property, plant and equipment

$6.4M

Shareholders' equity

$99.5M

Tangible book value

$96.5M

Tangible book value per share

$1.36

Total assets

$115.6M

Total cash

$101.6M

Total debt

$6.8M

Total liabilities

$16.1M

WACC

12.86%

Metric	Value
Asset turnover	0.01
Current assets	$105.7M
Current liabilities	$11M
Current ratio	9.63
Inventory turnover	8.24
Net working capital	$-5.2M
Quick ratio	9.27
Working capital	$94.7M
Working capital turnover	0.01

Metric

Value

Asset turnover

0.01

Current assets

$105.7M

Current liabilities

$11M

Current ratio

9.63

Inventory turnover

8.24

Net working capital

$-5.2M

Quick ratio

9.27

Working capital

$94.7M

Working capital turnover

0.01

Metric	Value
Buyback yield / dilution	-7.37%
Dividend yield	0%
Shareholder yield	-7.37%

Metric

Value

Buyback yield / dilution

-7.37%

Dividend yield

Shareholder yield

-7.37%

Metric	Value
10Y price change	798.99%
10Y return CAGR	24.56%
10Y total return	798.99%
150-day SMA	$35.00
1D price change	0.53%
1M price change	3.6%
1M total return	3.6%
1W price change	5.21%
1W total return	5.21%
1Y price change	205.66%
1Y return CAGR	205.89%
1Y total return	205.66%
20-day SMA	$50.15
200-day SMA	$30.95
3M price change	63.13%
3M total return	63.13%
3Y price change	1,182.73%
3Y return CAGR	134.04%
3Y total return	1,182.73%
50-day SMA	$50.82
50-day SMA vs 200-day SMA	50over200
52-week high	$58.90
52-week high date	2026-09-09
52-week low	$12.56
52-week low date	2025-11-20
5Y price change	160.42%
5Y return CAGR	21.1%
5Y total return	160.42%
6M price change	136.16%
6M total return	136.16%
All-time high	$58.90
All-time high date	2026-09-09
All-time low	$1.18
All-time low date	2022-08-30
Average true range (ATR)	$3.12
Average volume	386.6K
Beta (1Y)	0.74
Beta (2Y)	1.18
Beta (5Y)	1.57
Change from 52-week high	-9.2%
Change from 52-week low	325.8%
Change from all-time high	-9.19%
Change from all-time low	4,433.05%
Change from open	-0.35%
Day's gap	0.88%
Dollar volume	$12.7M
High price	$54.44
Low price	$52.98
Monthly RSI	84.94
Open price	$53.67
Position in 52-week range	34.25%
Premarket change	-2.26%
Premarket close	$53.20
Premarket price	$52.00
Previous close	$53.20
Price vs 150-day SMA	52.85%
Price vs 20-day SMA	6.67%
Price vs 200-day SMA	72.82%
Price vs 50-day SMA	5.25%
Relative volume	0.62
RSI	58.37
Sharpe ratio	1.63
Sharpe ratio (3Y)	1.37
Sharpe ratio (5Y)	0.61
Sortino ratio	3.35
Sortino ratio (3Y)	2.59
Sortino ratio (5Y)	1.08
Volume	238.4K
Weekly RSI	64.71
YTD price change	289.59%
YTD total return	289.59%

Metric

Value

10Y price change

798.99%

10Y return CAGR

24.56%

10Y total return

798.99%

150-day SMA

$35.00

1D price change

0.53%

1M price change

3.6%

1M total return

3.6%

1W price change

5.21%

1W total return

5.21%

1Y price change

205.66%

1Y return CAGR

205.89%

1Y total return

205.66%

20-day SMA

$50.15

200-day SMA

$30.95

3M price change

63.13%

3M total return

63.13%

3Y price change

1,182.73%

3Y return CAGR

134.04%

3Y total return

1,182.73%

50-day SMA

$50.82

50-day SMA vs 200-day SMA

50over200

52-week high

$58.90

52-week high date

2026-09-09

52-week low

$12.56

52-week low date

2025-11-20

5Y price change

160.42%

5Y return CAGR

21.1%

5Y total return

160.42%

6M price change

136.16%

6M total return

136.16%

All-time high

$58.90

All-time high date

2026-09-09

All-time low

$1.18

All-time low date

2022-08-30

Average true range (ATR)

$3.12

Average volume

386.6K

Beta (1Y)

0.74

Beta (2Y)

1.18

Beta (5Y)

1.57

Change from 52-week high

-9.2%

Change from 52-week low

325.8%

Change from all-time high

-9.19%

Change from all-time low

4,433.05%

Change from open

-0.35%

Day's gap

0.88%

Dollar volume

$12.7M

High price

$54.44

Low price

$52.98

Monthly RSI

84.94

Open price

$53.67

Position in 52-week range

34.25%

Premarket change

-2.26%

Premarket close

$53.20

Premarket price

$52.00

Previous close

$53.20

Price vs 150-day SMA

52.85%

Price vs 20-day SMA

6.67%

Price vs 200-day SMA

72.82%

Price vs 50-day SMA

5.25%

Relative volume

0.62

RSI

58.37

Sharpe ratio

1.63

Sharpe ratio (3Y)

1.37

Sharpe ratio (5Y)

0.61

Sortino ratio

3.35

Sortino ratio (3Y)

2.59

Sortino ratio (5Y)

1.08

Volume

238.4K

Weekly RSI

64.71

YTD price change

289.59%

YTD total return

289.59%

Metric	Value
Float	20.6M
Float percentage	28.95%
Shares change (QoQ)	1.77%
Shares change (YoY)	7.37%
Shares held by insiders	70.16%
Shares held by institutions	15.21%
Shares outstanding	71.3M
Short % of float	16.04%
Short % of shares	4.64%
Short ratio	4.7 days

Metric

Value

Float

20.6M

Float percentage

28.95%

Shares change (QoQ)

1.77%

Shares change (YoY)

7.37%

Shares held by insiders

70.16%

Shares held by institutions

15.21%

Shares outstanding

71.3M

Short % of float

16.04%

Short % of shares

4.64%

Short ratio

4.7 days

Pulse Biosciences, Inc. (PLSE)

Price

Financial snapshot

Fair-value bridge

Latest news · PLSE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PLSE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PLSE

Frequently asked questions